Cytovene injection and Insulin glargine and lixisenatide
Determining the interaction of Cytovene injection and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ganciclovir
Brand name: Cytovene
Synonyms: Cytovene (injection), Cytovene-IV
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cytovene injection-Insulin glargine and lixisenatide Subcutaneous
- Cytovene injection-Insulin glargine, recombinant Subcutaneous
- Cytovene injection-Insulin glulisine
- Cytovene injection-Insulin Glulisine (Cartridges and Pens)
- Cytovene injection-Insulin Glulisine (Vials)
- Cytovene injection-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Cytovene IV
- Insulin glargine and lixisenatide-Cytoxan
- Insulin glargine and lixisenatide-Cytoxan (Cyclophosphamide Injection)
- Insulin glargine and lixisenatide-Cytoxan (Cyclophosphamide Tablets)
- Insulin glargine and lixisenatide-Cytoxan Lyophilized
- Insulin glargine and lixisenatide-Cytra K Oral Solution